Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Caterina Carbonell
Observed names:
C. Carbonell,
Carbonell, Caterina
Institution:
Vall d'Hebron Institute of Oncology
Observed institutions:
Universitat Pompeu Fabra,
Amsterdam UMC Location University of Amsterdam,
Vall d'Hebron Hospital Universitari,
Vall d'Hebron Institute of Oncology,
University of Amsterdam
ORCID:
0000-0001-6508-1858
Observed ORCID:
0000-0001-6508-1858
OpenAlex ID:
A5013454241
Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
2011
·
E. Zurolo
, A. Iyer
, et al.
·
Brain
·
209
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy
2011
·
Eleonora Aronica
, Emanuele Zurolo
, et al.
·
Epilepsia
·
154
PDF
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
2022
·
Patricia Iranzo
, Ana Callejo
, et al.
·
Frontiers in Medicine
·
105
PDF
Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer
2020
·
Joan Frigola
, Alejandro Navarro
, et al.
·
Molecular Oncology
·
53
PDF
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
2021
·
Susana Cedres
, Juan-David Assaf
, et al.
·
Scientific Reports
·
27
PDF
Functional Network Analysis Reveals the Relevance of SKIIP in the Regulation of Alternative Splicing by p38 SAPK
2019
·
Caterina Carbonell
, Arnau Ulsamer
, et al.
·
Cell Reports
·
18
PDF
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study
2024
·
Elisabetta Petracci
, Luigi Pasini
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
14
PDF
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
2021
·
Ana Callejo
, Joan Frigola
, et al.
·
Cancers
·
14
PDF
Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
2023
·
Caterina Carbonell
, Joan Frigola
, et al.
·
Molecular Oncology
·
9
PDF
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
2022
·
Joan Frigola
, Caterina Carbonell
, et al.
·
Journal for ImmunoTherapy of Cancer
·
9
PDF
WNT pathway mutations (APC/CTNNB1) and immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients
2019
·
F.J. Ros Montana
, P. Iranzo
, et al.
·
Annals of Oncology
·
5
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
2023
·
Susana Cedres
, Garazi Serna
, et al.
·
Cancers
·
3
PDF
21P Circulating free and extracellular vesicles-derived microRNA as prognostic biomarkers in resected early-stage non-small cell lung cancer
2022
·
P. Ulivi
, L. Pasini
, et al.
·
Annals of Oncology
·
1
T-cell infiltration in matched samples from malignant pleural mesothelioma (MPM) during evolution of disease.
2022
·
Susana Cedres Perez
, Garazi Serna
, et al.
·
Journal of Clinical Oncology
·
1
MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
2021
·
S. Cedres
, J.D. Assaf
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Analysis of chemotherapy efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p).
2021
·
Susana Cedres Perez
, Juan David Assaf Pastrana
, et al.
·
Journal of Clinical Oncology
·
1
Immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients with WNT pathway mutations (APC/CTNNB1).
2020
·
Patricia Iranzo
, Ana Callejo
, et al.
·
Journal of Clinical Oncology
·
1
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
2026
·
Ilaria Priano
, Ramon Amat
, et al.
·
Genome Medicine
1935P Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
2025
·
I. Priano
, R. Caro
, et al.
·
Annals of Oncology
PDF
The complementary value of ctDNA and tissue NGS in lung cancer.
2025
·
Patricia Iranzo Gomez
, Gerard Romero-Sola
, et al.
·
Journal of Clinical Oncology
EP07.04-01 Free Circulating and Extracellular Vesicles-Derived microRNA as Prognostic Biomarkers in Resected Early-Stage NSCLC: RESTING Study Results
2023
·
L. Pasini
, E. Petracci
, et al.
·
Journal of Thoracic Oncology
PDF
EP14.04-02 Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients (p)
2023
·
S. Cedres
, G. Serna
, et al.
·
Journal of Thoracic Oncology
PDF
2193P Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
2023
·
S.M. Cedres Perez
, A.A. Valdivia
, et al.
·
Annals of Oncology
PDF
Author response for "Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC "
2023
·
Caterina Carbonell
, Joan Frigola
, et al.
·
Publons reviews and discussion
EP07.01-022 Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)
2022
·
S. Cedres
, L. Romero
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
33
Citation count:
625
H-index:
9
I10-index:
8
Year
Topic
Type